Combination Therapy with Liraglutide and Insulin in Japanese Subjects with Type 2 Diabetes: The LIRA-ADD2INSULIN JAPAN Trial

被引：0
|
作者：
Seino, Yutaka
Kaneko, Shizuka
Fukuda, Shuichi
Osonoi, Takeshi
Shiraiwa, Toshihiko
Nishijima, Keiji
Kaku, Kohei
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
985-P
引用
收藏
页码：A253 / A253
页数：1
相关论文
共 50 条
  • [1] COMBINATION THERAPY WITH LIRAGLUTIDE AND INSULIN IN JAPANESE SUBJECTS WITH TYPE 2 DIABETES: THE LIRA-ADD2INSULIN JAPAN TRIAL
    Seino, Y.
    Kaneko, S.
    Fukuda, S.
    Osonoi, T.
    Shiraiwa, T.
    Wang, F.
    Nishijima, K.
    Kaku, K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S37 - S37
  • [2] Addition of Liraglutide to OAD Monotherapy in Japanese Subjects with Type 2 Diabetes: The LIRA-ADD2OAD JAPAN Trial
    Kaku, Kohei
    Kiyosue, Arihiro
    Ono, Yuri
    Shiraiwa, Toshihiko
    Kaneko, Shizuka
    Nishijima, Keiji
    Seino, Yutaka
    DIABETES, 2014, 63 : A252 - A252
  • [3] ADDITION OF LIRAGLUTIDE TO OAD MONOTHERAPY IN JAPANESE SUBJECTS WITH TYPE 2 DIABETES: THE LIRA-ADD2OAD JAPAN TRIAL
    Kaku, K.
    Kiyosue, A.
    Ono, Y.
    Shiraiwa, T.
    Kaneko, S.
    Wang, F.
    Nishijima, K.
    Seino, Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S259 - S259
  • [4] A randomised, placebo-controlled trial of liraglutide as adjunct to basal insulin analogues in subjects with Type 2 diabetes (LIRA-ADD2BASAL)
    Bain, S. C.
    Ahmann, A.
    Rodbard, H. W.
    Rosenstock, J.
    Lahtela, J.
    de Loredo, L.
    Tornoe, K.
    Boopalan, A.
    Nauck, M.
    DIABETIC MEDICINE, 2015, 32 : 71 - 71
  • [5] Liraglutide in Combination with Insulin Therapy in Patients with Type 2 Diabetes
    Kern, W.
    DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (02): : 95 - 101
  • [6] Combination Therapy of Insulin and Liraglutide in Type 2 Diabetic Patients in Japan
    Yoshikawa, Yuichiro
    Kagaya, Hiroki
    Hirai, Keiji
    Kawakami, Soshi
    Imamura, Shigeki
    Hirai, Aizan
    DIABETES, 2014, 63 : A608 - A608
  • [7] EFFICACY AND SAFETY OF LIRAGLUTIDE VS PLACEBO WHEN ADDED TO BASAL INSULIN ANALOGUES IN SUBJECTS WITH TYPE 2 DIABETES (LIRA-ADD2BASAL): A RANDOMISED, PLACEBO-CONTROLLED TRIAL
    Ahmann, A.
    Rosenstock, J.
    Rodbard, H.
    Lahtela, J.
    de Loredo, L.
    Tornoe, K.
    Wang, F.
    Nauck, M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S254 - S255
  • [8] Efficacy and safety of liraglutide vs placebo when added to basal insulin analogues in subjects with type 2 diabetes (LIRA-ADD2BASAL): a randomised, placebo-controlled trial
    Lahtela, J.
    Ahmann, A.
    Rodbard, H.
    Rosenstock, J.
    de Loredo, L.
    Tornoe, K.
    Boopalan, A.
    Nauck, M.
    DIABETOLOGIA, 2014, 57 : S21 - S22
  • [9] Fixed Combination of Insulin Degludec and Liraglutide in Type 2 Diabetes Treatment
    Jaecke, E.
    Wilhelm, B.
    Kaiser, M.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (06): : 387 - 395
  • [10] Efficacy and Safety of Liraglutide Added to Insulin in Type 1 Diabetes: The LIRA-1 Trial
    Dejgaard, Thomas F.
    Frandsen, Christian S.
    Knop, Filip K.
    Tarnow, Lise
    Hansen, Tanja S.
    Almdal, Thomas
    Urhammer, Soren
    Jensen, Tonny
    Pedersen-Bjergaard, Ulrik
    Holst, Jens J.
    Madsbad, Sten
    Andersen, Henrik U.
    DIABETES, 2015, 64 : A73 - A73
12345